Insider Trading: Antares Pharma Inc (ATRS.O)

ATRS.O on Consolidated Issue listed on NASDAQ Capital Market

4.06USD
17 May 2013
Price Change (% chg)

$0.08 (+2.01%)
Prev Close
$3.98
Open
$4.00
Day's High
$4.07
Day's Low
$3.99
Volume
1,304,583
Avg. Vol
944,694
52-wk High
$5.58
52-wk Low
$2.60

Search Stocks
GARRITY THOMAS JOHN Options Exercised: 9,423
Trade Date: Sunday, 19 Aug 2012 Price: 3.97
Title: Director Shares Held: 103,741
Type Traded: Direct Net Change in Shares This Filing: 22,827

Institutional Holders

% Shares Owned: 36.89%
# of Holders: 103
Total Shares Held: 46,546,103
3 Mo. Net Change: 1,292,335
# New Positions: 14
# Closed Positions: 12
# Increased Positions: 55
# Reduced Positions: 33
# Net Buyers: 22

Officers & Directors

Name Age Since Current Position

Leonard Jacob

63 2008 Independent Chairman of the Board

Paul Wotton

51 2008 President, Chief Executive Officer, Director

Robert Apple

45 2009 Chief Financial Officer, Executive Vice President, President - Parenteral Products Division

Kaushik Dave

50 2011 Executive Vice President - Product Development

Peter Sadowski

64 2009 Senior Vice President, Chief Technology Officer

Thomas Garrity

63 2003 Independent Director

Jacques Gonella

70 2008 Independent Director

Anton Gueth

55 2003 Independent Director

Eamonn Hobbs

53 2009 Independent Director

Rajesh Shrotriya

68 2004 Independent Director
Search Stocks